Amniotic fluid inflammatory cytokines: Potential markers of immunologic dysfunction in autism spectrum disorders

World Journal of Biological Psychiatry

Volumn 14, Issue 7, 2013, Pages 528-538

  Abdallah, Morsi W ^a,b,c   Larsen, Nanna ^b   Grove, Jakob ^a   Norgaard Pedersen, Bent ^b   Thorsen, Poul ^d   Mortensen, Erik L ^c   Hougaard, David M ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d KOLDING HOSPITAL   (Denmark)

Author keywords

Amniotic fluid; Autistic disorder; Birth cohort; Cytokines; Maternal immune activation

Indexed keywords

CYTOKINE; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

AMNION FLUID; ARTICLE; AUTISM; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPATHOLOGY; INFECTION; MAJOR CLINICAL STUDY; MALE; MATERNAL DISEASE; MENTAL DISEASE; SEX DIFFERENCE;

ADULT; AGE OF ONSET; AMNIOTIC FLUID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COHORT STUDIES; COMPULSIVE PERSONALITY DISORDER; CYTOKINES; DENMARK; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; PREGNANCY; REGISTRIES;

EID: 84884254985     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2011.639803     Document Type: Article

References (66)

1. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Publishing, Inc.
2. Andersen TF, Madsen M, Jorgensen J, Mellemkjaer L, Olsen JH. 1999. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46(3): 263-268.
3. Ashdown H, Dumont Y, Ng M, Poole S, Boksa P, Luheshi GN. 2006. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry 11(1): 47-55.
4. Atladó ttir HÓ, Pedersen MG, Thorsen P, Mortensen PB, Deleuran B, Eaton, WW et al. 2009. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 124(2): 687-694.
5. Atladottir HO, Thorsen P, Schendel D, Ostergaard L, Abdallah M, Lemcke S, et al. 2010a. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord [Epub].
6. Atladottir HO, Thorsen P, Schendel DE, Ostergaard L, Lemcke S, Parner ET. 2010b. Association of hospitalization for infection in childhood with diagnosis of autism spectrum disorders: A Danish cohort study. Arch Pediatr Adolesc Med 164(5): 470-477.
7. Bradley Jr. 2008. TNF-mediated inflammatory disease. J Pathol 214(2): 149-160.
8. Chez MG, Dowling T, Patel PB, Khanna P, Kominsky M. 2007. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr Neurol 36(6): 361-365.
9. Chow SSW, Craig ME, Jones CA, Hall B, Catteau J, Lloyd AR et al. 2008. Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection. Cytokine 44(1): 78-84.
10. Croen LA, Grether JK, Yoshida CK, Odouli R, Van de Water J. 2005. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med 159(2): 151-157.
11. Croonenberghs J, Bosmans E, Deboutte D, Kenis G, Maes M. 2002. Activation of the inflammatory response system in autism. Neuropsychobiology 45(1): 1-6.
12. Denney JM, Nelson EL, Wadhwa PD, Waters TP, Mathew L, Chung EK et al. 2011. Longitudinal modulation of immune system cytokine profile during pregnancy. Cytokine 53(2): 170-177.
13. Deverman BE, Patterson PH. 2009. Cytokines and CNS development. Neuron 64(1): 61-78.
14. Goines P, Van de Water J. 2010. The immune system's role in the biology of autism. Curr Opin Neurol 23(2): 111.
15. Goines PE, Croen LA, Braunschweig D, Yoshida CK, Grether J, Hansen R et al. 2011. Increased mid-gestational IFN-gamma, IL-4, and IL-5 in women giving birth to a child with autism: a case-control study. Mol Autism 2(13): 1-11.
16. Gupta S, Aggarwal S, Rashanravan B, Lee T. 1998. Th1- and Th2-like cytokines in CD4 - and CD8 - T cells in autism. J Neuroimmunol 85(1): 106-109.
17. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, et al. 2011. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 68(11): 1095-1102.
18. Jonakait GM. 2007. The effects of maternal inflammation on neuronal development: possible mechanisms. Int J Dev Neurosci 25(7): 415-425.
19. Jyonouchi H, Sun S, Le H. 2001. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 120(1-2): 170-179.
20. Jyonouchi H, Geng L, Ruby A, Reddy C, Zimmerman-Bier B. 2005. Evaluation of an association between gastrointestinal symptoms and cytokine production against common dietary proteins in children with autism spectrum disorders. J Pediatr 146(5): 605-610.
21. Knudsen L, Olsen J. 1998. The Danish Medical Birth Registry. Dan Med Bull 45(3): 320.
22. Kugler KG, Hackl WO, Mueller LA, Fiegl H, Graber A, Pfeiffer RM. 2011. The impact of sample storage time on estimates of association in biomarker discovery studies. J Clin Bioinformatics 1(1): 1-8.
23. Larsson HJ, Eaton WW, Madsen KM, Vestergaard M, Olesen AV, Agerbo E, et al. 2005. Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status. Am J Epidemiol 161(10): 916-925.
24. Lauritsen M, Pedersen C, Mortensen P. 2004. The incidence and prevalence of pervasive developmental disorders: a Danish population-based study. Psychol Med 34(7): 1339-1346.
25. Lauritsen M, J ø rgensen M, Madsen K, Lemcke S, Toft S, Grove J, et al. 2010. Validity of childhood autism in the Danish psychiatric central register: findings from a cohort sample born 1990-1999. J Autism Dev Disord 40(2): 139-148.
26. Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, et al. 2009. Elevated immune response in the brain of autistic patients. J Neuroimmunol 207(1-2): 111-116.
27. Libbey JE, Sweeten TL, McMahon WM, Fujinami RS. 2005. Autistic disorder and viral infections. J Neurovirol 11(1): 1-10.
28. Luminex Corporation. Cytokines, chemokines, and growth factors [Internet] (available from: http: //www.luminexcorp.com/ applications/cytokine.html).
29. Meyer U, Feldon J, Yee BK. 2009. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 35(5): 959-972.
30. Meyer U, Feldon J, Damman O. 2011. Schizophrenia and autism: Both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res 69(5 Part 2): 26-33R (10.1203/ PDR.0b013e318212c196).
31. Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I, et al. 2006. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 26(18): 4752-4762.
32. Miles JH. 2011. Autism spectrum disorders-A genetics [Review]. Genet Med 13(4): 278-294.
33. Mocellin S, Marincola F, Riccardo Rossi C, Nitti D, Lise M. 2004. The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev 15(1): 61-76.
34. Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Courtney P, et al. 2006. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 172(1-2): 198-205.
35. Mortensen PB, N ø rgaard-Pedersen B, Waltoft BL, S ø rensen TL, Hougaard D, Torrey EF, et al. 2007. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry 61(5): 688-693.
36. Mortensen PB, Pedersen CB, Hougaard DM, N ø rgaard-Petersen B, Mors O, B ø rglum AD, et al. 2010. A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring. Schizophr Res 122(1-3): 257-263.
37. Mosbech J, J ø rgensen J, Madsen M, Rostgaard K, Thornberg K, Poulsen T. 1995. The national patient registry. Evaluation of data quality. Ugeskr Laeger 157(26): 3741.
38. Munk-Jorgensen P, Mortensen PB. 1997. The Danish Psychiatric Central Register. Dan Med Bull 44(1): 82-84.
39. Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE, et al. 2007. The epidemiology of autism spectrum disorders. Annu Rev Public Health 28: 235-258.
40. Nørgaard-Pedersen B. 2005. Statens Serum Institut: Etablering af en ny historisk prospektiv mor-barn biobank kohorte baseret p å ca. 100.000 gravidscreenings pr ø ver [Grant Application: Establishing a new historic prospective mother-child cohort based on approximately 100,000 antenatal screening samples at Statens Serum Institut]. Copenhagen: Statens Sundhedsvidenskabelige Forskningsr å d.
41. Nørgaard-Pedersen B, Hougaard DM. 2007. Storage policies and use of the Danish Newborn Screening Biobank. J Inherit Metab Dis 30(4): 530-536.
42. O'Shea JJ, Ma A, Lipsky P. 2002. Cytokines and autoimmunity. Nat Rev Immunol 2(1): 37-45.
43. Parker-Athill EC, Tan J. 2010. Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway. Neurosignals 18(2): 113-128.
44. Parner ET, Schendel DE, Thorsen P. 2008. Autism prevalence trends over time in Denmark: changes in prevalence and age at diagnosis. Arch Pediatr Adolesc Med 162(12): 1150-1156.
45. Patterson P, Xu W, Smith SEP, Devarman BE. 2008. Maternal immune activation, cytokines and autism. In: Zimmerman AW, editor. Autism: Current theories and evidence (Current Clinical Neurology). Totowa, NJ: Humana Press.
46. Pedersen C, G ø tzsche H, M ø ller J, Mortensen P. 2006. The Danish civil registration system. Dan Med Bull 53(4): 441-449.
47. Ratajczak HV. 2011. Theoretical aspects of autism: biomarkers-a review. J Immunotoxicol 8(1): 80-94.
48. Rice C. 2007. Prevalence of autism spectrum disorders: Autism and Developmental Disabilities Monitoring Network, Six Sites, United States, 2000. Atlanta, GA: CDC.
49. Rivet TT, Matson JL. 2011. Review of gender differences in core symptomatology in autism spectrum disorders. Res Autism Spectrum Disord 5(3): 957-976.
50. Ruddle NH. 1992. Tumor necrosis factor (TNF-[alpha]) and lymphotoxin (TNF-[beta]). Curr Opin Immunol 4(3): 327-332.
51. Sanderson C. 1992. Interleukin-5, eosinophils, and disease. Blood 79(12): 3101-3109.
52. Schendel D, Bhasin TK. 2008. Birth weight and gestational age characteristics of children with autism, including a comparison with other developmental disabilities. Pediatrics 121(6): 1155-1164.
53. Schlotz W, Phillips DIW. 2009. Fetal origins of mental health: Evidence and mechanisms. Brain Behav Immunity 23(7): 905-916.
54. Schneider T, Roman A, Basta-Kaim A, Kubera M, Budziszewska B, Schneider K, et al. 2008. Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 33(6): 728-740.
55. Skogstrand K, Thorsen P, Norgaard-Pedersen B, Schendel DE, Sorensen LC, Hougaard DM. 2005. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 51(10): 1854-1866.
56. Smith SEP, Patterson PH. 2009. Alteration of neurodevelopment and behavior by maternal immune activation. In: Siegel A, Zalcman SS, editors. The neuroimmunological basis of behavior and mental disorders. New York, NY. Springer. p 111-130.
57. Sperner-Unterweger B. 2005. Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications. Drugs 65(11): 1493-1520.
58. SPSS Inc. 2009. IBM PASW ® Statistics 18 (SPSS Statistics 18). 18th ed. Chicago, IL: SPSS Inc.
59. StataCorp LP. 2009. Stata statistics/data analysis, 11.2 ed. College Station, TX: StataCorp.
60. Strandberg-Larsen M, Nielsen MB, Vallgå rda S, Krasnik A, Vrangbæ k K. 2007. Denmark: Health system review. Copenhagen, Denmark: World Health Organization-European Observatory on Health Systems and Policies.
61. Sundhedsstyrelsen. 1986. Klassifikation af Sygdomme [Danish- Latin Version of International Classification of Diseases. 8th Revision. 1965]. Copenhagen: The Danish National Board of Health.
62. Sundhedsstyrelsen. Klassifikation af Sygdomme [Danish Version of International Classification of Diseases, 10th Revision] [Internet]. Copenhagen: The Danish National Board of Health. Available from: http: //www.medinfo.dk/ sks/brows.php?s-nod-4638
63. Takatsu K, Nakajima H. 2008. IL-5 and eosinophilia. Curr Opin Immunol 20(3): 288-294.
64. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP. 2008. Tumor necrosis factor antagonist mechanisms of action: A comprehensive review. Pharmacol Ther 117(2): 244-279.
65. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57(1): 67-81.
66. Wang H, Czuzra CJ, Tracey KJ. 2003. Tumour necrosis factoralpha. In: Thomson A, Lotze MT, editors. The cytokine handbook. 4th ed. London: Academic Press Limited. p 837-860.